Rockwell Medical, Inc.
RMTI
$0.69
$0.033.81%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -1,946.97% | -1,007.08% | -346.28% | 56.01% | 96.86% |
| Total Depreciation and Amortization | -0.46% | 0.55% | 0.09% | -0.91% | 18.86% |
| Total Amortization of Deferred Charges | 20.00% | -16.90% | -69.69% | -69.88% | -76.09% |
| Total Other Non-Cash Items | -8.56% | 3.30% | 22.07% | 12.96% | 4.22% |
| Change in Net Operating Assets | 162.13% | -5.63% | -48.82% | 84.31% | 51.62% |
| Cash from Operations | -14.02% | -115.68% | -163.30% | 173.87% | 139.10% |
| Capital Expenditure | 3.32% | 46.39% | -29.14% | -67.98% | -236.33% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -109.23% | -107.57% | -108.57% | -193.40% | -191.33% |
| Cash from Investing | -83.27% | -75.59% | -87.85% | 2.34% | 44.28% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.86% | 0.91% | 55.20% | 61.93% | 64.20% |
| Issuance of Common Stock | -18.76% | -23.23% | 54.91% | -57.91% | -37.61% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -17.92% | -45.55% | -142.43% | -49,900.00% | -41,200.00% |
| Cash from Financing | -33.90% | -42.13% | 112.45% | -74.40% | -47.44% |
| Foreign Exchange rate Adjustments | -- | -- | 66.67% | 33.33% | -400.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -137.52% | -174.13% | -72.22% | -78.68% | 211.69% |